An international team of researchers has found that an antibiotic commonly prescribed for patients with liver disease, called rifaximin, has led to the global emergence of an almost untreatable form ...
Researchers at Intermountain Health have been awarded a $356,000 grant from Merck, a global science and technology company ...
A small molecular strand could hold the key to solving one of the greatest global health challenges. When bacteria develop resistance to antibiotics, it can be deadly, but researchers have now decoded ...
(HealthDay News) — Treating hospitalized patients with bloodstream infections with antibiotics for 7 days is noninferior to treating for 14 days, according to a study presented at the annual eeting of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback